Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more pace logo pace ...
TAMPA, FLORIDA / ACCESSWIRE / January 10, 2025 / As the medical industry adapts to rapid regulatory changes, operational challenges, and evolving patient expectations, Black Book Research has ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma ...
New Over-the-Counter Cold Sore Treatment Cream Clevorx is Making Its Debut in the Healthcare Market, Offering Relief to Millions of Cold Sore ...
The Global Circulating Fluidized Bed Boilers Market is expected to increase at a compound annual growth rate (CAGR) of 3.7% ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD) in obesity-related disorders and myopathies announces the ...
Biotech startups often encounter administrative roadblocks on their path to achieving breakthroughs in life sciences. Today, ZAGENO, the leading AI-powered marketplace for lab supplies, and Hatch.Bio ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its high-performance HPV IgG ELISA Kit for the sensitive and specific ...
Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced today that they have formed an ...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...
Synaffix B.V. (“Synaffix”), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class ...